XML 134 R28.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Segment Information
 12 Months Ended
Dec. 31, 2019
Segment Reporting, Measurement Disclosures [Abstract]  
Segment Information SEGMENT INFORMATION
The Company operates and reports its results in three separate business segments consisting of the Life Sciences, Diagnostics and Environmental & Applied Solutions segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income and expense, interest and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Intersegment amounts are not significant and are eliminated to arrive at consolidated totals.
Detailed segment data for the years ended December 31 is as follows ($ in millions):
 
2019
 
2018
 
2017
Sales:
 
 
 
 
 
Life Sciences
$
6,951.1

 
$
6,471.4

 
$
5,710.1

Diagnostics
6,561.5

 
6,257.6

 
5,839.9

Environmental & Applied Solutions
4,398.5

 
4,319.5

 
3,968.8

Total
$
17,911.1

 
$
17,048.5

 
$
15,518.8

 
 
 
 
 
 
Operating profit:
 
 
 
 
 
Life Sciences
$
1,401.4

 
$
1,229.3

 
$
1,004.3

Diagnostics
1,134.1

 
1,073.8

 
871.6

Environmental & Applied Solutions
1,051.6

 
988.0

 
914.6

Other
(317.7
)
 
(236.0
)
 
(218.2
)
Total
$
3,269.4

 
$
3,055.1

 
$
2,572.3

 
 
 
 
 
 
Identifiable assets:
 
 
 
 
 
Life Sciences
$
22,381.3

 
$
22,122.4

 
$
20,576.8

Diagnostics
14,442.2

 
14,031.1

 
14,359.2

Environmental & Applied Solutions
4,881.8

 
4,637.3

 
4,649.2

Other
20,376.3

 
1,200.1

 
1,069.6

Discontinued operations
—

 
5,841.6

 
5,993.8

Total
$
62,081.6

 
$
47,832.5

 
$
46,648.6

 
 
 
 
 
 
Depreciation and amortization:
 
 
 
 
 
Life Sciences
$
487.1

 
$
471.2

 
$
427.9

Diagnostics
582.5

 
589.0

 
581.5

Environmental & Applied Solutions
110.6

 
109.0

 
99.9

Other
9.3

 
8.5

 
7.6

Total
$
1,189.5

 
$
1,177.7

 
$
1,116.9

 
 
 
 
 
 
Capital expenditures, gross:
 
 
 
 
 
Life Sciences
$
142.4

 
$
140.1

 
$
130.6

Diagnostics
434.4

 
380.0

 
372.6

Environmental & Applied Solutions
54.4

 
57.1

 
60.9

Other
4.3

 
6.3

 
6.6

Total
$
635.5

 
$
583.5

 
$
570.7

Operations in Geographical Areas:
 
Year Ended December 31
($ in millions)
2019
 
2018
 
2017
Sales:
 
 
 
 
 
United States
$
6,659.7

 
$
6,133.9

 
$
5,584.9

China
2,307.9

 
2,169.4

 
1,856.4

Germany
1,013.0

 
1,082.3

 
995.5

All other (each country individually less than 5% of total sales)
7,930.5

 
7,662.9

 
7,082.0

Total
$
17,911.1

 
$
17,048.5

 
$
15,518.8

 
 
 
 
 
 
Property, plant and equipment, net:
 
 
 
 
 
United States
$
1,076.8

 
$
1,080.3

 
$
1,008.2

Germany
162.7

 
169.2

 
180.9

United Kingdom
163.1

 
156.9

 
151.8

All other (each country individually less than 5% of total property, plant and equipment, net)
899.4

 
843.2

 
882.5

Total
$
2,302.0

 
$
2,249.6

 
$
2,223.4


Sales by Major Product Group:
 
Year Ended December 31
($ in millions)
2019
 
2018
 
2017
Analytical and physical instrumentation
$
2,463.8

 
$
2,437.0

 
$
2,232.9

Research and medical products
13,512.6

 
12,686.0

 
11,512.4

Product identification
1,934.7

 
1,925.5

 
1,773.5

Total
$
17,911.1

 
$
17,048.5

 
$
15,518.8